Investigating the Common Genetic Factors Linking Menopause Onset and Osteoarthritis
By
Bingru Luo
Lili Huang
Jing Zhou
Panpan Long
July 1, 2026
Clinical Scorecard: Investigating the Common Genetic Factors Linking Menopause Onset and Osteoarthritis
At a Glance
Category Detail
Condition Osteoarthritis (OA) Key Mechanisms Genetic factors, hormonal fluctuations, particularly estrogen levels, influence the development and progression of OA. Target Population Postmenopausal women and older adults. Care Setting Research and genetic epidemiology.
Key Highlights
OA prevalence has increased significantly from 1990 to 2020. Estrogen plays a protective role in joint health, with its decline post-menopause increasing OA risk. Genome-wide association studies (GWAS) have identified genetic loci linked to both OA and menopause onset. The genetic correlation between OA and menopause is an emerging area of research. Understanding genetic factors may lead to new preventive and therapeutic strategies. Guideline-Based Recommendations
Diagnosis
Radiographic evidence of OA is present in about 50% of individuals over 60 years of age. Management
Focus on hormonal regulation and genetic insights for potential therapeutic approaches. Monitoring & Follow-up
Monitor joint health and symptoms in postmenopausal women due to increased OA risk. Risks
Increased risk of OA associated with aging and hormonal changes in women. Patient & Prescribing Data
Individuals diagnosed with osteoarthritis, particularly postmenopausal women.
Potential for targeting genetic factors and hormonal therapies in management.
Clinical Best Practices
Utilize GWAS data to inform treatment strategies for OA. Consider hormonal levels in the assessment and management of OA in women. Related Resources & Content
